The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Person who experienced the adverse event (patient)

Event ID CASEID CASEVERSION I F COD EVENT DT MFR DT INIT FDA DT FDA DT REPT COD AUTH NUM MFR NUM MFR SNDR LIT REF AGE AGE COD AGE GRP GNDR COD E SUB WT WT COD REPT DT TO MFR OCCP COD REPORTER COUNTRY OCCR COUNTRY
125490253 12549025 3 F 20160207 20160928 20160712 20160929 EXP US-PFIZER INC-3198717 PFIZER 52.00 YR M Y 145.00000 KG 20160929 OT US US

Drug(s) used by person

Event ID CASEID DRUG SEQ ROLE COD DRUGNAME PROD AI VAL VBM ROUTE DOSE VBM CUM DOSE CHR CUM DOSE UNIT DECHAL RECHAL LOT NUM EXP DT NDA NUM DOSE AMT DOSE UNIT DOSE FORM DOSE FREQ
125490253 12549025 1 SS EPOGEN ERYTHROPOIETIN 1 Intravenous (not otherwise specified) 8200 IU, UNK UNK 0 8200 IU
125490253 12549025 2 SS EPOGEN ERYTHROPOIETIN 1 Intravenous (not otherwise specified) 5200 IU, UNK UNK 0 5200 IU
125490253 12549025 3 PS ALPRAZOLAM. ALPRAZOLAM 1 Oral 2 MG, AS NEEDED Y 18276 2 MG
125490253 12549025 4 SS HYDROMORPHONE HYDROCHLORIDE. HYDROMORPHONE HYDROCHLORIDE 1 Intravenous (not otherwise specified) 1 MG, AS NEEDED, EVERY 4 HOURS Y 74598 1 MG
125490253 12549025 5 SS MORPHINE SULFATE. MORPHINE SULFATE 1 Intravenous (not otherwise specified) 2 MG, AS NEEDED Y 19999 2 MG
125490253 12549025 6 SS HYDROCODONE BITARTRATE AND ACETAMINOPHEN ACETAMINOPHENHYDROCODONE BITARTRATE 1 Oral 10 MG/325 MG, ONCE D 0 1 DF
125490253 12549025 7 SS TRAMADOL. TRAMADOL 1 Oral 50 MG, AS NEEDED 0 50 MG
125490253 12549025 8 SS ATIVAN LORAZEPAM 1 Intravenous (not otherwise specified) 1 MG, 2 DOSES 0 1 MG
125490253 12549025 9 SS HALOPERIDOL LACTATE. HALOPERIDOL LACTATE 1 Intravenous (not otherwise specified) 5 MG, ONCE Y 0 5 MG
125490253 12549025 10 SS HALOPERIDOL LACTATE. HALOPERIDOL LACTATE 1 Intravenous (not otherwise specified) 10 MG, ONCE Y 0 10 MG
125490253 12549025 11 C IRON IRON 1 UNK UNK 0

Indications of drugs used

Event ID CASEID INDI DRUG SEQ INDI PT
125490253 12549025 1 Nephrogenic anaemia
125490253 12549025 3 Agitation
125490253 12549025 4 Arthralgia
125490253 12549025 5 Arthralgia
125490253 12549025 6 Arthralgia
125490253 12549025 7 Arthralgia
125490253 12549025 8 Agitation
125490253 12549025 9 Agitation
125490253 12549025 11 Nephrogenic anaemia

Outcome of event

Event ID CASEID OUTC COD
125490253 12549025 LT
125490253 12549025 HO

Reactions reported

Event ID CASEID DRUG REC ACT PT
125490253 12549025 Osteomyelitis
125490253 12549025 Respiratory arrest
125490253 12549025 Tibia fracture

Reporting Sources (this data is often not reported and may therefore be missing here)

no results found

Therapies reported

Event ID CASEID DSG DRUG SEQ START DT END DT DUR DUR COD
125490253 12549025 1 20151218 0
125490253 12549025 2 20151226 0
125490253 12549025 3 20160207 20160209 0
125490253 12549025 4 20160207 20160210 0
125490253 12549025 5 20160207 20160209 0
125490253 12549025 6 20160207 20160207 0
125490253 12549025 7 20160208 20160208 0
125490253 12549025 8 20160210 20160210 0
125490253 12549025 9 20160210 20160210 0
125490253 12549025 10 20160210 20160210 0